to examiner
on 19 Mar 2024
Last Applicant/ Owned by
5-1, Marunouchi 1-chome, Chiyoda-ku
Tokyo
JP
100-8405
Serial Number
97526680 filed on 29th Jul 2022
Registration Number
N/A
Correspondent Address
Jeffrey H. Kaufman
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
"BIOLOGICS"
Biotechnology research; chemical research; research and development services in the field of antibodies being antibody technology "BIOLOGICS" Antibody physicochemical fractionation of culture fluid or for cells purification for others, namely, custom manufacture of pharmaceuticals; Antibody physicochemical fractionation of culture fluid or for cells purification for others in the nature of biomaRead More
Biotechnology research; chemical research; research and development services in the field of antibodies being antibody technology
31st Jan 2018
31st Jan 2018
Antibody physicochemical fractionation of culture fluid or for cells purification for others, namely, custom manufacture of pharmaceuticals; Antibody physicochemical fractionation of culture fluid or for cells purification for others in the nature of biomanufacturing for others, namely, manufacturing of pharmaceuticals using biological organisms in the manufacturing process; custom manufacture of biopharmaceuticals by pharmaceutical compounders by contract manufacturing organization
31st Jan 2018
31st Jan 2018
No 97526680
No Service Mark
No AGC00021
No
No
No
No
No
No
No
No
| Status Date | Action Taken |
|---|---|
| 19th Mar 2024 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| 19th Mar 2024 | STATEMENT OF USE PROCESSING COMPLETE |
| 27th Feb 2024 | TEAS STATEMENT OF USE RECEIVED |
| 27th Feb 2024 | USE AMENDMENT FILED |
| 29th Aug 2023 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| 04th Jul 2023 | PUBLISHED FOR OPPOSITION |
| 04th Jul 2023 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 14th Jun 2023 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| 26th May 2023 | EXAMINERS AMENDMENT -WRITTEN |
| 26th May 2023 | EXAMINERS AMENDMENT E-MAILED |
